All Stories

  1. The Effectiveness of a New Topical Formulation Containing GSH-C4 and Hyaluronic Acid in Seborrheic Dermatitis: Preliminary Results of an Exploratory Pilot Study
  2. Small Molecules, Big Promises: Improvement of Psoriasis Severity and Glucidic Markers with Apremilast: A Case Report
  3. Omalizumab for chronic spontaneous urticaria in “complex” patients: data from real-life clinical practice
  4. Skin immunity and its dysregulation in psoriasis
  5. Investigational drugs currently in phase II clinical trials for actinic keratosis
  6. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial
  7. New local treatment for photoaging using a formulation containing piroxicam 0.8% and sunscreen
  8. Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the fa...
  9. Clinical evidence on the efficacy and tolerability of a topical medical device containing benzoylperoxide 4%, retinol 0.5%, mandelic acid 1% and lactobionic acid 1% in the treatment of mild facial acne: an open label pilot study
  10. Apremilast efficacy and safety in a psoriatic arthritis patient affected by HIV and HBV virus infections
  11. Current developments in pharmacotherapy for actinic keratosis
  12. Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study
  13. Bednar Tumour Occurring after Malignant Melanoma Excision
  14. Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90
  15. New insight into the pathogenesis of nail psoriasis and overview of treatment strategies
  16. Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics
  17. Fungistatic activity of all-trans retinoic acid against Aspergillus fumigatus and Candida albicans
  18. The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors
  19. Tazarotene as alternative topical treatment for onychomycosis
  20. Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma
  21. Dermoscopy as an adjuvant tool for detecting skin leiomyomas in patient with uterine fibroids and cerebral cavernomas
  22. Pyoderma gangrenosum in refractory celiac disease: a case report
  23. Confocal reflectance microscopy in pityriasis rubra pilaris
  24. Connexin 26 (GJB2) mutations, causing KID Syndrome, are associated with cell death due to calcium gating deregulation
  25. Connexin 26 (GJB2) mutations as a cause of the KID syndrome with hearing loss
  26. Topical Treatment of Actinic Keratoses with Piroxicam 1% Gel
  27. Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia
  28. Treatment of disfiguring chronic graft versus host disease in a child with topical pimecrolimus
  29. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis
  30. Bilateral Thoracoscopic T2 to T3 Sympathectomy Versus Botulinum Injection in Palmar Hyperhidrosis
  31. Relation Between Animal-Type Melanoma and Reduced Nuclear Expression of Glutathione S-Transferase π
  32. Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness
  33. Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face
  34. Cerebral Cavernomas in a Family with Multiple Cutaneous and Uterine Leiomyomas Associated with a New Mutation in the Fumarate Hydratase Gene
  35. Childhood Nail Psoriasis: A Useful Treatment with Tazarotene 0.05%
  36. Imiquimod Treatment of Superficial and Nodular Basal Cell Carcinoma: 12-Week Open-Label Trial
  37. Imiquimod Treatment of Superficial and Nodular Basal Cell Carcinoma
  38. Evidence of Increased Apoptosis and Reduced Proliferation in Basal Cell Carcinomas Treated with Tazarotene
  39. Ink Spot Lentigo Arising on Naevus Spilus Simulating Melanoma
  40. Dermatomyositis associated with ovarian transitional cell carcinoma